{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Consortium",
      "Data integration",
      "Heterogeneity",
      "Meta-analysis",
      "Pathway analysis",
      "Pedigree studies"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "31437624",
  "DateCompleted": {
    "Year": "2020",
    "Month": "12",
    "Day": "15"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "04",
    "Day": "02"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2019",
        "Month": "08",
        "Day": "19"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.semcancer.2019.08.021",
      "S1044-579X(19)30203-2"
    ],
    "Journal": {
      "ISSN": "1096-3650",
      "JournalIssue": {
        "Volume": "61",
        "PubDate": {
          "Year": "2020",
          "Month": "Apr"
        }
      },
      "Title": "Seminars in cancer biology",
      "ISOAbbreviation": "Semin Cancer Biol"
    },
    "ArticleTitle": "Statistical genomics in rare cancer.",
    "Pagination": {
      "StartPage": "1",
      "EndPage": "10",
      "MedlinePgn": "1-10"
    },
    "Abstract": {
      "AbstractText": [
        "Rare cancers make of more than 20% of cancer cases. Due to the rare nature, less research has been conducted on rare cancers resulting in worse outcomes for patients with rare cancers compared to common cancers. The ability to study rare cancers is impaired by the ability to collect a large enough set of patients to complete an adequately powered genomic study. In this manuscript we outline analytical approaches and public genomic datasets that have been used in genomic studies of rare cancers. These statistical analysis approaches and study designs include: gene set / pathway analyses, pedigree and consortium studies, meta-analysis or horizontal integration, and integration of multiple types of genomic information or vertical integration. We also discuss some of the publicly available resources that can be leveraged in rare cancer genomic studies."
      ],
      "CopyrightInformation": "Copyright \u00a9 2019 Elsevier Ltd. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biostatistics & Bioinformatics, Moffitt Cancer Center, Tampa, FL, 33612, USA. Electronic address: farnooshbabazadeh@gmail.com."
          }
        ],
        "LastName": "Abbas-Aghababazadeh",
        "ForeName": "Farnoosh",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biostatistics & Bioinformatics, Moffitt Cancer Center, Tampa, FL, 33612, USA. Electronic address: Qianxing.Mo@moffitt.org."
          }
        ],
        "LastName": "Mo",
        "ForeName": "Qianxing",
        "Initials": "Q"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biostatistics & Bioinformatics, Moffitt Cancer Center, Tampa, FL, 33612, USA. Electronic address: Brooke.Fridley@moffitt.org."
          }
        ],
        "LastName": "Fridley",
        "ForeName": "Brooke L",
        "Initials": "BL"
      }
    ],
    "GrantList": [
      {
        "GrantID": "P30 CA076292",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Meta-Analysis",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Semin Cancer Biol",
    "NlmUniqueID": "9010218",
    "ISSNLinking": "1044-579X"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Computational Biology"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Gene Expression Profiling"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genetic Association Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genetic Predisposition to Disease"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genetics, Population"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Genomics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Models, Theoretical"
    },
    {
      "QualifierName": [
        "diagnosis",
        "epidemiology",
        "genetics",
        "therapy"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pedigree"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Public Health Surveillance"
    },
    {
      "QualifierName": [
        "diagnosis",
        "epidemiology",
        "genetics",
        "therapy"
      ],
      "DescriptorName": "Rare Diseases"
    }
  ],
  "CoiStatement": "Declaration of Competing Interest None declared."
}